{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:58:09Z","timestamp":1794301089284,"version":"4.9.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Peptides constitute a well-established and rapidly expanding field in the contemporary pharmaceutical drug landscape. Studies with\n                    <jats:sup>14<\/jats:sup>\n                    C- or\n                    <jats:sup>3<\/jats:sup>\n                    H-radiolabeled analogs are the gold standard for drug development, yet access to\n                    <jats:sup>14<\/jats:sup>\n                    C-peptides is costly and limited to derivatization of the native structure with tags or lengthy multi-step syntheses. In this work, we report a platform that installs\n                    <jats:sup>14<\/jats:sup>\n                    C- or\n                    <jats:sup>3<\/jats:sup>\n                    H-radiolabeled lysine residues directly on solid-supported peptides. The workflow constitutes a mild, peptide-compatible hydroformylation process of allylglycine residues to generate labeled allysine, followed by reductive amination that furnishes radiolabeled lysine residues directly upon cleavage from the solid support. The hydroformylation setup can be tuned for flexible isotope introduction by using\n                    <jats:sup>14<\/jats:sup>\n                    CO from solid precursors and\n                    <jats:sup>3<\/jats:sup>\n                    H\n                    <jats:sub>2<\/jats:sub>\n                    from standard tritium manifolds. We show that the optimized workflow tolerates diverse sequences and enables functionalization of peptides as complex as semaglutide analogs.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-74115-8","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T20:53:00Z","timestamp":1781297580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Late-stage generation of 14C\/3H-radiolabeled lysine residues via hydroformylation of peptides"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4200-7390","authenticated-orcid":false,"given":"Anika","family":"Schick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"San Jose Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Christian D. Hammersh\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3971-4652","authenticated-orcid":false,"given":"Johan","family":"Broddefalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4819-0854","authenticated-orcid":false,"given":"Pablo","family":"Mart\u00ednez-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3099-2544","authenticated-orcid":false,"given":"Vitus J.","family":"Enem\u00e6rke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"von Sydow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Holub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranganath","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3700-0891","authenticated-orcid":false,"given":"Kim S.","family":"M\u00fchlfenzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8090-5050","authenticated-orcid":false,"given":"Troels","family":"Skrydstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7434-8307","authenticated-orcid":false,"given":"Charles S.","family":"Elmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"74115_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","volume":"7","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Therapeutic peptides: current applications and future directions. Sig. Transduct. Target. Ther. 7, 48 (2022).","journal-title":"Sig. Transduct. Target. Ther."},{"key":"74115_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/ph16030336","volume":"16","author":"O Al Musaimi","year":"2023","unstructured":"Al Musaimi, O., Al Shaer, D., Albericio, F. & de la Torre, B. G. 2022 FDA TIDES (Peptides and Oligonucleotides) harvest. Pharmaceuticals 16, 336 (2023).","journal-title":"Pharmaceuticals"},{"key":"74115_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","volume":"20","author":"M Muttenthaler","year":"2021","unstructured":"Muttenthaler, M., King, G. F., Adams, D. J. & Alewood, P. F. Trends in peptide drug discovery. Nat. Rev. Drug Discov. 20, 309\u2013325 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"74115_CR4","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s13300-020-00894-y","volume":"11","author":"S Kalra","year":"2020","unstructured":"Kalra, S. & Sahay, R. A review on semaglutide: an oral glucagon-like peptide 1 receptor agonist in management of type 2 diabetes mellitus. Diab. Ther. 11, 1965\u20131982 (2020).","journal-title":"Diab. Ther."},{"key":"74115_CR5","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","volume":"28","author":"WT Garvey","year":"2022","unstructured":"Garvey, W. T. et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat. Med. 28, 2083\u20132091 (2022).","journal-title":"Nat. Med."},{"key":"74115_CR6","doi-asserted-by":"publisher","first-page":"104160","DOI":"10.1016\/j.drudis.2024.104160","volume":"29","author":"KDS Fernald","year":"2024","unstructured":"Fernald, K. D. S., F\u00f6rster, P. C., Claassen, E. & van de Burgwal, L. H. M. The pharmaceutical productivity gap - Incremental decline in R&D efficiency despite transient improvements. Drug Discov. Today 29, 104160 (2024).","journal-title":"Drug Discov. Today"},{"key":"74115_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3681","volume":"11","author":"JW Scannell","year":"2012","unstructured":"Scannell, J. W., Blanckley, A., Boldon, H. & Warrington, B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 11, 191\u2013200 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"74115_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.drudis.2013.11.014","volume":"19","author":"RA Roberts","year":"2014","unstructured":"Roberts, R. A. et al. Reducing attrition in drug development: smart loading preclinical safety assessment. Drug Discov. Today 19, 341\u2013347 (2014).","journal-title":"Drug Discov. Today"},{"key":"74115_CR9","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","volume":"12","author":"D Sun","year":"2022","unstructured":"Sun, D., Gao, W., Hu, H. & Zhou, S. Why 90% of clinical drug development fails and how to improve it? Acta Pharm. Sin. B 12, 3049\u20133062 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"74115_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202306019","volume":"62","author":"V Derdau","year":"2023","unstructured":"Derdau, V. et al. The future of (radio)-labeled compounds in research and development within the life science industry. Angew. Chem. Int. Ed. 62, e202306019 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"74115_CR11","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1124\/dmd.123.001437","volume":"51","author":"MM He","year":"2023","unstructured":"He, M. M. et al. Metabolism and excretion of therapeutic peptides: current industry practices, perspectives, and recommendations. Drug Metab. Dispos. 51, 1436\u20131450 (2023).","journal-title":"Drug Metab. Dispos."},{"key":"74115_CR12","doi-asserted-by":"publisher","first-page":"32383","DOI":"10.1039\/D2RA06236D","volume":"12","author":"MR Edelmann","year":"2022","unstructured":"Edelmann, M. R. Radiolabelling small and biomolecules for tracking and monitoring. RSC Adv. 12, 32383\u201332400 (2022).","journal-title":"RSC Adv."},{"key":"74115_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejps.2017.03.020","volume":"104","author":"L Jensen","year":"2017","unstructured":"Jensen, L. et al. Absorption, metabolism and excretion of the GLP-1 analogue semaglutide in humans and nonclinical species. Eur. J. Pharm. Sci. 104, 31\u201341 (2017).","journal-title":"Eur. J. Pharm. Sci."},{"key":"74115_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature22800","volume":"546","author":"A Jazayeri","year":"2017","unstructured":"Jazayeri, A. et al. Crystal structure of the GLP-1 receptor bound to a peptide agonist. Nature 546, 254\u2013258 (2017).","journal-title":"Nature"},{"key":"74115_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jlcr.1941","volume":"55","author":"MHF Pedersen","year":"2012","unstructured":"Pedersen, M. H. F. & Baun, M. Tritium labelling of PACAP-38 using a synthetic diiodinated precursor peptide. J. Label. Compd. Radiopharm. 55, 1\u20134 (2012).","journal-title":"J. Label. Compd. Radiopharm."},{"key":"74115_CR16","doi-asserted-by":"publisher","first-page":"8159","DOI":"10.1002\/anie.201804010","volume":"57","author":"M Valero","year":"2018","unstructured":"Valero, M., Weck, R., G\u00fcssregen, S., Atzrodt, J. & Derdau, V. Highly selective directed iridium-catalyzed hydrogen isotope exchange reactions of aliphatic amides. Angew. Chem. Int. Ed. 57, 8159\u20138163 (2018).","journal-title":"Angew. Chem. Int. Ed."},{"key":"74115_CR17","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1039\/C8CC00653A","volume":"54","author":"L Gao","year":"2018","unstructured":"Gao, L. et al. Ruthenium-catalyzed hydrogen isotope exchange of C(sp3)\u2013H bonds directed by a sulfur atom. Chem. Commun. 54, 2986\u20132989 (2018).","journal-title":"Chem. Commun."},{"key":"74115_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-69850-x","volume":"17","author":"E Martinelli","year":"2026","unstructured":"Martinelli, E., Weck, R., G\u00fcssregen, S. & Derdau, V. Radiolabeling of oligopeptides by selective hydrogen isotope exchange with deuterium and tritium in aqueous buffers. Nat. Commun. 17, 2317 (2026).","journal-title":"Nat. Commun."},{"key":"74115_CR19","doi-asserted-by":"publisher","first-page":"12738","DOI":"10.1002\/chem.202003464","volume":"26","author":"F Legros","year":"2020","unstructured":"Legros, F. et al. Photoredox-mediated hydrogen isotope exchange reactions of amino-acids, peptides, and peptide-derived drugs. Chem. Eur. J. 26, 12738\u201312742 (2020).","journal-title":"Chem. Eur. J."},{"key":"74115_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/0024-3205(84)90302-3","volume":"34","author":"BC Wilkes","year":"1984","unstructured":"Wilkes, B. C. et al. Synthesis of tritium labeled Ac-[Nle4, D-Phe7]-\u03b1-MSH4\u221211-NH2: a superpotent melanotropin with prolonged biological activity. Life Sci. 34, 977\u2013984 (1984).","journal-title":"Life Sci."},{"key":"74115_CR21","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1021\/acsomega.2c06758","volume":"8","author":"MR Edelmann","year":"2023","unstructured":"Edelmann, M. R., Erny, J., Guba, W. & Hierl, M. Tritium labeling of neuromedin S by conjugation with [3H]N-succinimidyl propionate. ACS Omega 8, 2367\u20132376 (2023).","journal-title":"ACS Omega"},{"key":"74115_CR22","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1021\/acs.jmedchem.5b01495","volume":"59","author":"M Keller","year":"2016","unstructured":"Keller, M. et al. Mimicking of arginine by functionalized N\u03c9-carbamoylated arginine as a new broadly applicable approach to labeled bioactive peptides: high affinity angiotensin, neuropeptide Y, neuropeptide FF, and neurotensin receptor ligands as examples. J. Med. Chem. 59, 1925\u20131945 (2016).","journal-title":"J. Med. Chem."},{"key":"74115_CR23","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1021\/acs.molpharmaceut.6b00687","volume":"13","author":"G Jacquot","year":"2016","unstructured":"Jacquot, G. et al. Optimization and in vivo validation of peptide vectors targeting the LDL receptor. Mol. Pharm. 13, 4094\u20134105 (2016).","journal-title":"Mol. Pharm."},{"key":"74115_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/jlcr.3777","volume":"62","author":"A Dell\u2019isola","year":"2019","unstructured":"Dell\u2019isola, A. et al. Synthesis of carbon-14-labelled peptides. J. Label. Compd. Radiopharm. 62, 713\u2013717 (2019).","journal-title":"J. Label. Compd. Radiopharm."},{"key":"74115_CR25","doi-asserted-by":"publisher","first-page":"6953","DOI":"10.1021\/acs.jmedchem.2c00401","volume":"65","author":"H Cahuzac","year":"2022","unstructured":"Cahuzac, H. et al. Monitoring in vivo performances of protein\u2013drug conjugates using site-selective dual radiolabeling and ex vivo digital imaging. J. Med. Chem. 65, 6953\u20136968 (2022).","journal-title":"J. Med. Chem."},{"key":"74115_CR26","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1021\/acs.orglett.7b01068","volume":"19","author":"A Skogh","year":"2017","unstructured":"Skogh, A., Friis, S. D., Skrydstrup, T. & Sandstr\u00f6m, A. Palladium-catalyzed aminocarbonylation in solid-phase peptide synthesis: a method for capping, cyclization, and isotope labeling. Org. Lett. 19, 2873\u20132876 (2017).","journal-title":"Org. Lett."},{"key":"74115_CR27","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1002\/chem.202005261","volume":"27","author":"SS Pedersen","year":"2021","unstructured":"Pedersen, S. S. et al. A nickel(II)-mediated thiocarbonylation strategy for carbon isotope labeling of aliphatic carboxamides. Chem. Eur. J. 27, 7114\u20137123 (2021).","journal-title":"Chem. Eur. J."},{"key":"74115_CR28","doi-asserted-by":"publisher","first-page":"110126","DOI":"10.1016\/j.cclet.2024.110126","volume":"36","author":"J Li","year":"2025","unstructured":"Li, J., Chen, J., Hu, Q.-L., Wang, Z. & Xiong, X.-F. Recent progress of chemical methods for lysine site-selective modification of peptides and proteins. Chin. Chem. Lett. 36, 110126 (2025).","journal-title":"Chin. Chem. Lett."},{"key":"74115_CR29","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1039\/C1CC14711K","volume":"48","author":"D Chakraborty","year":"2012","unstructured":"Chakraborty, D., Islam, K. & Luo, M. Facile synthesis and altered ionization efficiency of diverse N\u03b5-alkyllysine-containing peptides. Chem. Commun. 48, 1514\u20131516 (2012).","journal-title":"Chem. Commun."},{"key":"74115_CR30","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1039\/C4OB02348J","volume":"13","author":"R Wodtke","year":"2015","unstructured":"Wodtke, R. et al. Cyclopeptides containing the DEKS motif as conformationally restricted collagen telopeptide analogues: synthesis and conformational analysis. Org. Biomol. Chem. 13, 1878\u20131896 (2015).","journal-title":"Org. Biomol. Chem."},{"key":"74115_CR31","doi-asserted-by":"publisher","first-page":"e202403215","DOI":"10.1002\/anie.202403215","volume":"63","author":"B Emenike","year":"2024","unstructured":"Emenike, B., Shahin, S. & Raj, M. Bioinspired synthesis of allysine for late-stage functionalization of peptides. Angew. Chem. Int. Ed. 63, e202403215 (2024).","journal-title":"Angew. Chem. Int. Ed."},{"key":"74115_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49223-y","volume":"15","author":"X Fang","year":"2024","unstructured":"Fang, X. et al. Electrochemical synthesis of peptide aldehydes via C\u2012N bond cleavage of cyclic amines. Nat. Commun. 15, 5181 (2024).","journal-title":"Nat. Commun."},{"key":"74115_CR33","doi-asserted-by":"publisher","first-page":"11095","DOI":"10.1039\/D5CC02404H","volume":"61","author":"G-H Feng","year":"2025","unstructured":"Feng, G.-H., Wang, T.-Y. & Li, Y.-M. Recent developments in late-stage protein modification. Chem. Commun. 61, 11095\u201311117 (2025).","journal-title":"Chem. Commun."},{"key":"74115_CR34","doi-asserted-by":"publisher","first-page":"19096","DOI":"10.1002\/anie.201910888","volume":"58","author":"AFM Noisier","year":"2019","unstructured":"Noisier, A. F. M. et al. Late-stage functionalization of histidine in unprotected peptides. Angew. Chem. Int. Ed. 58, 19096\u201319102 (2019).","journal-title":"Angew. Chem. Int. Ed."},{"key":"74115_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp9958","volume":"10","author":"Y Xiao","year":"2024","unstructured":"Xiao, Y. et al. Clickable tryptophan modification for late-stage diversification of native peptides. Sci. Adv. 10, eadp9958 (2024).","journal-title":"Sci. Adv."},{"key":"74115_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202201339","volume":"28","author":"M Werner","year":"2022","unstructured":"Werner, M., Pampel, J., Pham, T. L. & Thomas, F. Late-stage functionalisation of peptides on the solid phase by an iodination-substitution approach. Chem. Eur. J. 28, e202201339 (2022).","journal-title":"Chem. Eur. J."},{"key":"74115_CR37","doi-asserted-by":"publisher","first-page":"7950","DOI":"10.1039\/D4CC02442G","volume":"60","author":"A Benny","year":"2024","unstructured":"Benny, A. & Scanlan, E. M. Synthesis of macrocyclic thiolactone peptides via photochemical intramolecular radical acyl thiol\u2013ene ligation. Chem. Commun. 60, 7950\u20137953 (2024).","journal-title":"Chem. Commun."},{"key":"74115_CR38","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1021\/bi011762p","volume":"41","author":"B Wang","year":"2002","unstructured":"Wang, B., Brown, K. C., Lodder, M., Craik, C. S. & Hecht, S. M. Chemically mediated site-specific proteolysis. Alteration of protein-protein interaction. Biochemistry 41, 2805\u20132813 (2002).","journal-title":"Biochemistry"},{"key":"74115_CR39","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1021\/cr3001803","volume":"112","author":"R Franke","year":"2012","unstructured":"Franke, R., Selent, D. & B\u00f6rner, A. Applied hydroformylation. Chem. Rev. 112, 5675\u20135732 (2012).","journal-title":"Chem. Rev."},{"key":"74115_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s40828-021-00154-x","volume":"8","author":"B Zhang","year":"2021","unstructured":"Zhang, B., Pe\u00f1a Fuentes, D. & B\u00f6rner, A. Hydroformylation. ChemTexts 8, 2 (2021).","journal-title":"ChemTexts"},{"key":"74115_CR41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s44160-022-00223-0","volume":"2","author":"HCD Hammersh\u00f8j","year":"2023","unstructured":"Hammersh\u00f8j, H. C. D. et al. Multi-carbon labelling of active pharmaceutical ingredients enabled by a three-gas surrogate hydroformylation. Nat. Synth. 2, 243\u2013250 (2023).","journal-title":"Nat. Synth."},{"key":"74115_CR42","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41929-020-00510-z","volume":"3","author":"SK Pedersen","year":"2020","unstructured":"Pedersen, S. K. et al. Main element chemistry enables gas-cylinder-free hydroformylations. Nat. Catal. 3, 843\u2013850 (2020).","journal-title":"Nat. Catal."},{"key":"74115_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF01050659","volume":"1","author":"LJ Wittenberg","year":"1981","unstructured":"Wittenberg, L. J. Report on conference: American nuclear society topical meeting, tritium technology in fission, fusion, and isotopic applications, Dayton, Ohio, April 29\u2013May 1, 1980. J. Fusion Energy 1, 155\u2013161 (1981).","journal-title":"J. Fusion Energy"},{"key":"74115_CR44","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/1099-1344(20001015)43:11<1135::AID-JLCR404>3.0.CO;2-T","volume":"43","author":"CS Elmore","year":"2000","unstructured":"Elmore, C. S., Dean, D. C. & Melillo, D. G. A convenient method for [14C] carbonylation reactions. J. Label. Compd. Radiopharm. 43, 1135\u20131144 (2000).","journal-title":"J. Label. Compd. Radiopharm."},{"key":"74115_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/jlcr.2962","volume":"55","author":"AT Lindhardt","year":"2012","unstructured":"Lindhardt, A. T. et al. 14Carbon monoxide made simple \u2013 novel approach to the generation, utilization, and scrubbing of 14carbon monoxide. J. Label. Compd. Radiopharm. 55, 411\u2013418 (2012).","journal-title":"J. Label. Compd. Radiopharm."},{"key":"74115_CR46","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1021\/jacsau.2c00030","volume":"2","author":"V Babin","year":"2022","unstructured":"Babin, V., Taran, F. & Audisio, D. Late-stage carbon-14 labeling and isotope exchange: emerging opportunities and future challenges. JACS Au. 2, 1234\u20131251 (2022).","journal-title":"JACS Au"},{"key":"74115_CR47","doi-asserted-by":"crossref","unstructured":"Elmore, C. S., Chapter 25 the use of isotopically labeled compounds in drug discovery. In Annual Reports in Medicinal Chemistry Vol. 44 (ed. John. E. M.) 515\u2013534 (Academic Press, 2009).","DOI":"10.1016\/S0065-7743(09)04425-X"},{"key":"74115_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40136-w","volume":"14","author":"S Monticelli","year":"2023","unstructured":"Monticelli, S. et al. Unlocking full and fast conversion in photocatalytic carbon dioxide reduction for applications in radio-carbonylation. Nat. Commun. 14, 4451 (2023).","journal-title":"Nat. Commun."},{"key":"74115_CR49","doi-asserted-by":"publisher","first-page":"6608","DOI":"10.1021\/ja0348997","volume":"125","author":"B Breit","year":"2003","unstructured":"Breit, B. & Seiche, W. Hydrogen bonding as a construction element for bidentate donor ligands in homogeneous catalysis: regioselective hydroformylation of terminal alkenes. J. Am. Chem. Soc. 125, 6608\u20136609 (2003).","journal-title":"J. Am. Chem. Soc."},{"key":"74115_CR50","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/adsc.201300258","volume":"355","author":"AT Straub","year":"2013","unstructured":"Straub, A. T., Otto, M., Usui, I. & Breit, B. Room temperature ambient pressure (RTAP)-hydroformylation in water using a self-assembling ligand. Adv. Synth. Catal. 355, 2071\u20132075 (2013).","journal-title":"Adv. Synth. Catal."},{"key":"74115_CR51","doi-asserted-by":"crossref","unstructured":"Kijewska, M. et al. Solid-phase synthesis of peptides containing aminoadipic semialdehyde moiety and their cyclisations. Sci. Rep. 8, 10462 (2018).","DOI":"10.1038\/s41598-018-28798-9"},{"key":"74115_CR52","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1039\/b209087m","volume":"27","author":"E Teoh","year":"2003","unstructured":"Teoh, E., Campi, E. M., Jackson, W. R. & Robinson, A. J. One-pot tandem enantioselective hydrogenation\u2013hydroformylation synthesis of cyclic \u03b1-amino acids. N. J. Chem. 27, 387\u2013394 (2003).","journal-title":"N. J. Chem."},{"key":"74115_CR53","doi-asserted-by":"publisher","first-page":"e202509939","DOI":"10.1002\/anie.202509939","volume":"64","author":"SJ Paravizzini","year":"2025","unstructured":"Paravizzini, S. J., Haugaard-Kedstr\u00f6m, L. M., Hutton, C. A. & Karas, J. A. Backbone protecting groups for enhanced peptide and protein synthesis. Angew. Chem. Int. Ed. 64, e202509939 (2025).","journal-title":"Angew. Chem. Int. Ed."},{"key":"74115_CR54","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1021\/jo00070a041","volume":"58","author":"SK Sharma","year":"1993","unstructured":"Sharma, S. K. et al. Reductive amination with tritylamine as an ammonia equivalent: efficient preparation of the 5-(4-(9-fluorenylmethyloxycarbonyl)aminomethyl-3,5-dimethoxyphenoxy)valeric acid (PAL) handle for peptide synthesis. J. Org. Chem. 58, 4993\u20134996 (1993).","journal-title":"J. Org. Chem."},{"key":"74115_CR55","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.1021\/ja200818w","volume":"133","author":"P Hermange","year":"2011","unstructured":"Hermange, P. et al. Ex situ generation of stoichiometric and substoichiometric 12CO and 13CO and its efficient incorporation in palladium catalyzed aminocarbonylations. J. Am. Chem. Soc. 133, 6061\u20136071 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"74115_CR56","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1021\/acs.accounts.5b00471","volume":"49","author":"SD Friis","year":"2016","unstructured":"Friis, S. D., Lindhardt, A. T. & Skrydstrup, T. The development and application of two-chamber reactors and carbon monoxide precursors for safe carbonylation reactions. Acc. Chem. Res. 49, 594\u2013605 (2016).","journal-title":"Acc. Chem. Res."},{"key":"74115_CR57","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1021\/cb700186x","volume":"2","author":"OA Timofeeva","year":"2007","unstructured":"Timofeeva, O. A. et al. Rationally designed inhibitors identify STAT3 N-domain as a promising anticancer drug target. ACS Chem. Biol. 2, 799\u2013809 (2007).","journal-title":"ACS Chem. Biol."},{"key":"74115_CR58","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1021\/acsomega.9b03226","volume":"5","author":"Y Yamamoto","year":"2020","unstructured":"Yamamoto, Y. et al. Facile hydrogenative deprotection of N-benzyl groups using a mixed catalyst of palladium and niobic acid-on-carbon. ACS Omega 5, 2699\u20132709 (2020).","journal-title":"ACS Omega"},{"key":"74115_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/frne.1999.0183","volume":"20","author":"YC Patel","year":"1999","unstructured":"Patel, Y. C. Somatostatin and its receptor family. Front. Neuroendocrinol. 20, 157\u2013198 (1999).","journal-title":"Front. Neuroendocrinol."},{"key":"74115_CR60","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1111\/liv.14703","volume":"40","author":"AV Kulkarni","year":"2020","unstructured":"Kulkarni, A. V. et al. Terlipressin has stood the test of time: clinical overview in 2020 and future perspectives. Liver Int. 40, 2888\u20132905 (2020).","journal-title":"Liver Int."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74115-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74115-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74115-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:03:26Z","timestamp":1781600606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74115-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74115"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74115-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.S. is co-owner of SyTracks A\/S, which commercializes COware\u00ae (two-chamber system and heat block), SilaCOgen, and COgen. M.S.J.G. and A.H. are Sanofi employees and may hold shares and\/or stock options in the company. J.B., R.G., P.M.P., L.S., K.S.M., A.S., and C.E. are or were AstraZeneca employees and may hold shares and\/or stock options in the company. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5307"}}